+ Watch CSKI
on My Watchlist
The company develops, manufactures, markets, and sells over-the-counter, branded nutritional supplements, and over-the-counter plant- and herb-based pharmaceuticals primarily in China.
More cash on balance sheet than the market cap of the stock. Plus, continued positive cash flow and profits with an improved outlook for future products. Company is sticking with R&D spending for future growth.
There is no cash at all! If there was any, management would buy this company with instant profit!
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions